In contrast, for BRAF− melanoma, no statistically significant differences were observed in survival times between the high- and low-expression groups of LOXL3, NES, and SNAI1 (p = 0.14, p = 0.81, and p = 0.07, respectively) (Figure 6). Here, LOXL3 is linked to melanoma.